share_log

S-1: General form for registration of securities under the Securities Act of 1933

S-1: General form for registration of securities under the Securities Act of 1933

S-1:证券上市注册声明
美股sec公告 ·  04/16 17:26
Moomoo AI 已提取核心信息
Applied UV, Inc. (Applied UV), a Nevada-based company specializing in disinfection technology, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on April 16, 2024, for a Form S-1 Registration Statement. The company, which operates through its subsidiaries SteriLumen, Inc. and Munn Works, LLC, is known for its air and surface disinfection products that serve various markets including healthcare, hospitality, and food preservation. The registration statement pertains to the proposed sale of 518,065 shares of common stock, issuable upon the exercise of warrants from a private placement conducted on April 1, 2024. The selling stockholders may sell these shares through public or private transactions, and the company will not receive any proceeds from the sale of shares by the...Show More
Applied UV, Inc. (Applied UV), a Nevada-based company specializing in disinfection technology, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on April 16, 2024, for a Form S-1 Registration Statement. The company, which operates through its subsidiaries SteriLumen, Inc. and Munn Works, LLC, is known for its air and surface disinfection products that serve various markets including healthcare, hospitality, and food preservation. The registration statement pertains to the proposed sale of 518,065 shares of common stock, issuable upon the exercise of warrants from a private placement conducted on April 1, 2024. The selling stockholders may sell these shares through public or private transactions, and the company will not receive any proceeds from the sale of shares by the selling stockholders. However, if the warrants are exercised for cash, Applied UV may receive approximately $8.3 million, intended for general corporate purposes, including working capital. The common stock is listed on The Nasdaq Capital Market under the symbol 'AUVI'. The company's stock price has been subject to fluctuations, and investing in the common stock involves a high degree of risk. The registration statement includes detailed information about the company's business, financial condition, and the risks associated with the offering.
总部位于内华达州的专门从事消毒技术的公司应用紫外线公司(Applied UV)已于2024年4月16日向美国证券交易委员会(SEC)提交了S-1表格注册声明的注册声明。该公司通过其子公司SteriluMen, Inc.和Munn Works, LLC运营,以其空气和表面消毒产品而闻名,这些产品服务于医疗保健、酒店和食品保鲜等各个市场。注册声明涉及518,065股普通股的拟议出售,这些普通股可在行使2024年4月1日进行的私募认股权证后发行。出售股东可以通过公开或私人交易出售这些股票,并且公司不会从出售股票的股东出售股票中获得任何收益。但是,如果认股权证以现金行使,则Applied UV可能获得约830万美元,用于一般公司用途,包括营运资金。普通股在纳斯达克资本市场上市,股票代码为 “AUVI”。该公司的股价一直受到波动,投资普通股涉及很高的风险。注册声明包括有关公司业务、财务状况以及与本次发行相关的风险的详细信息。
总部位于内华达州的专门从事消毒技术的公司应用紫外线公司(Applied UV)已于2024年4月16日向美国证券交易委员会(SEC)提交了S-1表格注册声明的注册声明。该公司通过其子公司SteriluMen, Inc.和Munn Works, LLC运营,以其空气和表面消毒产品而闻名,这些产品服务于医疗保健、酒店和食品保鲜等各个市场。注册声明涉及518,065股普通股的拟议出售,这些普通股可在行使2024年4月1日进行的私募认股权证后发行。出售股东可以通过公开或私人交易出售这些股票,并且公司不会从出售股票的股东出售股票中获得任何收益。但是,如果认股权证以现金行使,则Applied UV可能获得约830万美元,用于一般公司用途,包括营运资金。普通股在纳斯达克资本市场上市,股票代码为 “AUVI”。该公司的股价一直受到波动,投资普通股涉及很高的风险。注册声明包括有关公司业务、财务状况以及与本次发行相关的风险的详细信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息